Prudential Financial’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,403
Closed -$25.9K 2485
2025
Q1
$25.9K Hold
2,403
﹤0.01% 2239
2024
Q4
$30.8K Sell
2,403
-4,845
-67% -$96K ﹤0.01% 2254
2024
Q3
$200K Hold
7,248
﹤0.01% 2516
2024
Q2
$210K Buy
7,248
+2,450
+51% +$117K ﹤0.01% 2472
2024
Q1
$214K Buy
4,798
+2,195
+84% +$94K ﹤0.01% 2453
2023
Q4
$101K Hold
2,603
﹤0.01% 2501
2023
Q3
$76.5K Hold
2,603
﹤0.01% 2466
2023
Q2
$166K Buy
2,603
+1,980
+318% +$110K ﹤0.01% 2451
2023
Q1
$29.4K Sell
623
-5
-0.8% -$267 ﹤0.01% 2545
2022
Q4
$43.6K Buy
628
+4
+0.6% +$397 ﹤0.01% 2504
2022
Q3
$92K Buy
624
+6
+1% +$812 ﹤0.01% 2518
2022
Q2
$81K Buy
618
+70
+13% +$7.15K ﹤0.01% 2543
2022
Q1
$55K Buy
+548
New +$66.4K ﹤0.01% 2569

Other funds holding LYEL